Research
Metabolic adaptation
Semaglutide users had higher rates of pneumonia (2.97 % vs 0.85 %, p < 0.05) compared to non-users.
Clinicians should be aware of the increased risk of pneumonia in patients using semaglutide.
StrongSupportsmedium confidence
Semaglutide users had higher rates of pneumonia (2.97 % vs 0.85 %, p < 0.05) compared to nonusers.
Why this rating
Based on a retrospective analysis with matched controls.
Source
The impact of semaglutide use for weight loss on transforaminal lumbar interbody fusion outcomes
Syed Khalid et al. · Clinical Neurology and Neurosurgery · 2025
other · n=942Cited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →